64 reports

  • Treatment Chart for Management of Acne as per AAD* Guidelines

Oral Contraceptives b.

  • Dermatological Condition
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • Treatment Chart for Management of Acne as per AAD* Guidelines

Oral Contraceptives b.

  • Dermatological Condition
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • COMMON ORAL CONTRACEPTIVE FORMULATIONS
  • COMMON PRESCRIPTION HYPERPIGMENTATION/MELASMA

TABLE ##-##: COMMON ORAL CONTRACEPTIVE FORMULATIONS RESEARCH AND DEVELOPMENT ON JANUARY ##, 2017, ALLERGAN RECEIVED FDA APPROVAL OF RHOFADE, AN OXYMETAZOLINE HYDROCHLORIDE ##% CREAM.

  • Breast Cancer
  • Dermatological Condition
  • World
  • Market Size
  • Galderma S.A.
  • Acne Treatment - An Overview

Porter Five Force Analysis ##.

  • Dermatological Condition
  • North America
  • World
  • Market Size
  • Allergan plc
  • PRESENTS A LIST OF THE MOST COMMONLY USED TREATMENTS FOR THE MANAGEMENT OF ACNE BY THERAPEUTIC CLASS.
  • 7.3 INCREASED PATIENT AND CAREGIVER AWARENESS

THE ROLE OF COMBINED ORAL CONTRACEPTIVES IN THE MANAGEMENT OF ACNE AND SEBORRHEA.

  • Breast Cancer
  • Dermatological Condition
  • Foamix Ltd.
  • Galderma S.A.
  • Novan, Inc.

Other systematic therapies include oral contraceptives, spironolactone and isotretinoin.

  • Dermatological Condition
  • World
  • Market Size
  • Actavis plc
  • Allergan plc
  • KEY DISEASES - ACNE VULGARIS (1/2)

In an acquisition purchase of one company by another (usually, a smaller company by a larger one).

  • Dermatological Condition
  • Beiersdorf AG
  • Estee Lauder Companies Inc.
  • L'Oreal S.A.
  • Procter & Gamble Company
  • Treatment Chart for Management of Acne as per AAD* Guidelines

Desogestrel and Ethinyl Estradiol is an oral contraceptive which is prescribed for prevention of pregnancy in women.

  • Dermatological Condition
  • Allergan plc
  • Cipla Ltd
  • Novartis AG
  • Sun Pharmaceutical Industries Limited
  • 1.1 Acne

Combination and estrogen contraceptives are usually recommended in such cases while progesterone-only contraceptives can make acne worse.

  • Dermatological Condition
  • Therapy
  • Forecast
  • Allergan plc
  • Foamix Ltd.
  • 4.1.1 ETIOLOGY
  • 5.7.1 EPIDEMIOLOGICAL FORECAST INSIGHT

Oral Contraceptive and Cancer Risks.

  • Breast Cancer
  • Dermatological Condition
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • Use of contraceptives or antiandrogen drugs
  • Acne: An overview

You can easily book an appointment with one online.

  • Acne Treatment
  • Dermatological Condition
  • Pharmaceutical
  • Allergan plc
  • Galderma S.A.
  • 2.3 Etiology
  • 9.3 Bibliography

Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.

  • Breast Cancer
  • Dermatological Condition
  • AstraZeneca PLC
  • Novartis AG
  • Roche Group

During Solo-## and Solo-## patients were randomized ##:##:## to receive either placebo, Dupixent ##mg once weekly or ##mg Dupixent every other week with a placebo in-between.

  • Dermatological Condition
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.
  • Apricus Biosciences, Inc.
  • HUGE MARKET POTENTIAL FOR BREAST CANCER MABS OWING TO PRODUCT APPROVALS

For instance, the use of hormonal therapy after menopause and the use of contraceptives are potential risks for developing breast cancer.

  • Breast Cancer
  • Amgen Inc.
  • Biocon Limited
  • Mylan Inc.
  • Roche Group
  • 3.1 ETIOLOGY AND PATHOPHYSIOLOGY

Combination hormone products, such as the estrogen + progestin contraceptive pill, have also been associated with an increased risk of breast cancer (NCI, 2016).

  • Breast Cancer
  • Dermatological Condition
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • 2.1.2 Causes of Breast Cancer

The Aptima HIV-## Quant assay is not approved for HIV-## diagnosis in the United States.

  • Breast Cancer
  • Dermatological Condition
  • World
  • Business Expansion & Exit
  • Hologic, Inc.
  • Breast Cancer Therapeutics Market, Taiwan, Market Size ($m), 2015-2022
  • Breast Cancer Therapeutics, South Korea, Age-Specific Incidence (%), 2012

Oral contraceptives and breast cancer risk in Taiwan, a country of low Journal of the National Cancer incidence of breast cancer and low use of oral contraceptives.

  • Breast Cancer
  • Dermatological Condition
  • Market Size
  • Genentech, Inc.
  • Novartis AG

For instance, the use of hormonal therapy after menopause and the use of contraceptives are potential risks for developing breast cancer.

  • Breast Cancer
  • Dermatological Condition
  • World
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.

Approximately one third of the US population suffers from at least one active dermatological condition (Johnson, 2004).

  • Dermatological Condition
  • Market Size
  • Allergan plc
  • Apricus Biosciences, Inc.
  • Pfizer Inc.
  • 2.7.1 Epidemiological Forecast Insight

Chronic Diseases and Translational Medicine; ##(##): ##-##.

  • Breast Cancer
  • China
  • Japan
  • United States
  • Forecast

Immunology and Allergy Clinics of North America; ##(##): ##- ## Lebwohl MG, et al. (2013).

  • Dermatological Condition
  • Market Size
  • Amgen Inc.
  • Biologics, Inc.
  • Merck & Co., Inc.
  • JOHNSON & JOHNSON
  • DESCRIPTION OF PRODUCTS

Ortho McNeil has a long history of research and product marketing in oral contraceptives and is globally recognized as a leader in contraceptive products.

  • Breast Cancer
  • Dermatological Condition
  • Allergan plc
  • Galderma S.A.
  • Pfizer Inc.

These include oral contraceptive use, multiple pregnancies and prolonged lactation.

  • Breast Cancer
  • Dermatological Condition
  • Market Size
  • Celgene Corporation
  • Merck & Co., Inc.
  • REFERRAL IS DICTATED BY STAGE AT DIAGNOSIS AND ELECTED TREATMENT APPROACH

Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, et al. (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.

  • Breast Cancer
  • European Union
  • Japan
  • United States
  • TESARO, Inc.
  • 2.3 ETIOLOGY

Combination hormone products, such as the estrogen and progestin contraceptive pill, have also been associated with an increased risk of breast cancer (NCI, 2013).

  • Breast Cancer
  • Dermatological Condition
  • Market Size
  • Novartis AG
  • Pfizer Inc.

Quartette is an oral contraceptive indicated for the prevention of pregnancy.

  • Breast Cancer
  • Dermatological Condition
  • United States
  • World
  • Product Initiative
  • NOV 14, 2017: FASLODEX (FULVESTRANT) RECEIVES EU APPROVAL FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE ADVANCED BREAST CANCER IN COMBINATION WITH PALBOCICLIB
  • DEC 06, 2017: H3 BIOMEDICINE PRESENTS PRECLINICAL DATA ON NOVEL ERA ANTAGONIST AT SAN ANTONIO BREAST CANCER SYMPOSIUM

We believe that Estelle has the potential to become a true ' next - generation' contraceptive option, including in North America, a market worth ##% of the USD ##bn worldwide contraceptive market.

  • Breast Cancer
  • Dermatological Condition
  • Hormone
  • Hospital
  • Mithra
  • 14. Market Growth Drivers

The use of hormonal therapy after menopause and the use of contraceptives are potential risks for developing the disease.

  • Breast Cancer
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Hoffmann-La Roche Inc.
  • (ER+) breast cancer. The trial was registered with the U.S. National Institutes of Health.

Similarly, the universities portfolio in Phase II, Preclinical and Discovery stages comprises ##, ## and ## molecules, respectively.

  • Breast Cancer
  • Dermatological Condition
  • Hormone
  • United States
  • Product Initiative
  • GLOBAL INCIDENCE OF BREAST CANCER, 2012-2025
  • MARKET DYNAMICS (2/10)

This can majorly be attributed to changing lifestyles, increasing use of oral contraceptives, and the growing number of women undergoing cosmetic surgeries such as breast enhancement.

  • Breast Cancer
  • North America
  • United States
  • Forecast
  • Cianna Medical, Inc.